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Abstract
Background:  Affymetrix GeneChips®  are widely used for expression profiling of tens of
thousands of genes. The large number of comparisons can lead to false positives. Various methods
have been used to reduce false positives, but they have rarely been compared or quantitatively
evaluated. Here we describe and evaluate a simple method that uses the detection (Present/
Absent) call generated by the Affymetrix microarray suite version 5 software (MAS5) to remove
data that is not reliably detected before further analysis, and compare this with filtering by
expression level. We explore the effects of various thresholds for removing data in experiments of
different size (from 3 to 10 arrays per treatment), as well as their relative power to detect
significant differences in expression.
Results: Our approach sets a threshold for the fraction of arrays called Present in at least one
treatment group. This method removes a large percentage of probe sets called Absent before
carrying out the comparisons, while retaining most of the probe sets called Present. It preferentially
retains the more significant probe sets (p ≤ 0.001) and those probe sets that are turned on or off,
and improves the false discovery rate. Permutations to estimate false positives indicate that probe
sets removed by the filter contribute a disproportionate number of false positives. Filtering by
fraction Present is effective when applied to data generated either by the MAS5 algorithm or by
other probe-level algorithms, for example RMA (robust multichip average). Experiment size greatly
affects the ability to reproducibly detect significant differences, and also impacts the effect of
filtering; smaller experiments (3–5 samples per treatment group) benefit from more restrictive
filtering (≥50% Present).
Conclusion: Use of a threshold fraction of Present detection calls (derived by MAS5) provided a
simple method that effectively eliminated from analysis probe sets that are unlikely to be reliable
while preserving the most significant probe sets and those turned on or off; it thereby increased
the ratio of true positives to false positives.
Background
Affymetrix GeneChips® are routinely used to measure rel-
ative amounts of mRNA transcripts on a genome wide
basis. The large number of probe sets (representing genes)
available on these arrays gives the researcher a wealth of
information, but the multiple testing raises the potential
Published: 31 January 2006
BMC Bioinformatics2006, 7:49 doi:10.1186/1471-2105-7-49
Received: 27 June 2005
Accepted: 31 January 2006
This article is available from: http://www.biomedcentral.com/1471-2105/7/49
© 2006McClintick and Edenberg; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Bioinformatics 2006, 7:49 http://www.biomedcentral.com/1471-2105/7/49
Page 2 of 16
(page number not for citation purposes)
for a large number of false positives. False positives and
false negatives can both pose problems for the researcher,
each with its own cost, so the balance between the two
should be evaluated based upon the goals of the experi-
ment. Increasing the stringency for accepting differences
as significant (decreasing p-value) reduces false positives,
which is important if verification and follow-up are costly,
but simultaneously reduces true positives and may lead
investigators to miss important trends in the data. Meas-
urements of false positive risk, such as false discovery rate
(FDR) [1,2], are now commonly used to help guide deci-
sions. Although FDR gives the investigator an estimate of
how many false positives to expect, it does nothing to
identify which results are false positives.
Methods that differentially eliminate data that are likely
to be unreliable can be of great help to the investigator.
Not all genes are expected to be expressed at levels that are
either biologically significant or detectable by the Affyme-
trix technology (1–3 copies per cell) in any particular tis-
sue; in fact, the subset of genes expressed is what
determines the characteristics of each tissue. For example,
Jongeneel, et al. [3] estimated that 10,000–15,000 tran-
scripts are expressed in human cell lines at one copy per
cell or above. Data for genes not actually expressed repre-
sent experimental noise and cannot increase true posi-
tives, but can (and do) generate false positives. Discarding
data for genes that are not expressed at detectable levels is,
therefore, justified by biology and should result in an
improvement in the balance between true and false posi-
tives.
Each Affymetrix GeneChip® probe set contains 8 to 16
paired perfect match (PM) and mismatch (MM) 25-mer
probes, which are used to determine whether a given gene
is expressed and to measure the expression level (signal)
[4]. The Affymetrix Microarray Suite version 5 (MAS5)
algorithm uses the probe-pair data in different ways to cal-
culate the detection call and the signal. MAS5 uses a non-
parametric statistical test (Wilcoxon signed rank test) of
whether significantly more perfect matches show more
hybridization signal than their corresponding mis-
matches to produce the detection call (Absent (A), Present
(P) or Marginal (M)) for each probe set [5]. We will use
the convention of capitalized Present, Absent, and Mar-
ginal to indicate the formal detection calls. The signal is
the anti-log of an average (Tukey biweight) of the log(PM-
MMadj) for all of the probe pairs, where MMadj is equal
to MM or an adjusted quantity which will produce a pos-
itive value [6]. Genes that are not detectably expressed
nevertheless generate signal values, usually low; random
fluctuations in these low values can often produce large
apparent fold-changes.
Distribution of MAS5 log2(signals) before and after filtering Figure 1
Distribution of MAS5 log2(signals) before and after 
filtering. A) No filter. B) Filtering with threshold of ≥ 50% 
Present in at least one treatment group. C) Filtering by aver-
age signal with threshold at ≥475 in at least one treatment 
group. The number of probe-sets at each value of Log2(sig-
nal) are plotted. Black = Present, gray = Marginal, white = 
Absent.
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Different methods have been used to pre-filter data to
remove data for probe sets that are believed to be less reli-
able, but the effects of such pre-filtering are rarely ana-
lyzed quantitatively. Filtering by signal (expression level)
[7] removes probe sets with signal close to background;
the choice of how close to background is arbitrary.
Removal of probe sets that are called Absent on all arrays
has been reported [8]. Some use post-hoc methods by
eliminating significant probe sets with low fold changes
[9]; again, the choice of fold-change is arbitrary and there
is no theoretical null distribution. Others use combina-
tions of these strategies: trimming upper and lower signals
plus fold change filter [10]; confidence score based on
fold change, p-value, signal and percent Present [11]; sig-
nal, fold change and percent Present filters [12]; mini-
mum signal and fold change [13]. Most of these studies
did not provide a reference for their selection of filtering
criteria or provide evidence that these strategies were help-
ful. Aston et al. [12] chose their fold-change threshold
based on fold changes seen in previous microarray studies
of post-mortem brain tissue, but technical variations
between experiments can affect the distribution of signals.
Stossi et al. [11] provided two references for their confi-
dence score but neither of these gave a rationale for the
calculation. Seo, et al. demonstrated that using the MAS5
detection p-value as a weighting factor in the distance
measures for hierarchical clustering increased the ability
to separate samples from biologically different groups
[14].
We have filtered out probe sets that were not called
Present by the MAS5 detection call in at least 50% of the
samples in one treatment group [15,16]. Requiring the
probe set to meet the criterion in any one treatment group
retains genes that are turned on or off; these are usually
very interesting to biologists. Our method, which we call
filtering by fraction Present, improves FDR. Here, we eval-
uate the effects of setting different thresholds and com-
pare this approach to the use of thresholds for signal
values. These analyses were performed using expression
level data generated by two widely used algorithms, MAS5
and RMA (robust multichip average [17,18]). RMA is an
alternative log scale measurement of expression derived
from only the perfect match probes by fitting them to a
linear model normalized across all arrays in the experi-
ment. RMA does not provide a measure comparable to the
MAS5 detection call. We examined the effects of the frac-
tion Present filtering on the ability to detect changes in
expression using a parametric t-test and also using a per-
mutation-based test, significance analysis of microarrays
(SAM) [19]. We also explore how experiment size can
affect the ability to detect differences in gene expression,
and how the sample size interacts with the choice of filter-
ing thresholds, using permutations of the full data set to
create virtual experiments of smaller sample sizes. These
Distribution of RMA values before and after filtering Figure 2
Distribution of RMA values before and after filtering. 
A) No filter. B) Filtering with threshold of ≥ 50% Present in 
at least one treatment group. C) Filtering by average RMA 
value with threshold at ≥5.03 in at least one treatment group. 
Symbols as in Fig. 1.
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analyses provide useful guidelines for improving the
design and interpretation of microarray experiments.
Results
Distribution of signal and RMA values
The a priori expectation is that not all genes are expressed
in any given tissue at levels detectable by Affymetrix Gene-
Chip® arrays (1–3 transcripts per cell) [3]. It therefore
makes both biological and statistical sense to avoid ana-
lyzing differences in the apparent expression of genes that
are not truly expressed. To compare two methods of filter-
ing out such probe sets, we examined a dataset that com-
pares 10 arrays from cells without interferon to 10 arrays
from cells treated with interferon alpha (IFN dataset [16]).
Of the 445,660 individual probe sets (20 arrays with
22,283 probe sets per array) in the IFN data set, 54% were
called Absent by the MAS5 algorithm. There is a strong
suggestion of bimodality in the distribution of log2(sig-
nal) for all probe sets (Fig. 1A), with a large number of
Absent probe sets forming a shoulder at low signal values.
Removing probe sets in which fewer than half of the
arrays in at least one of the experimental groups was called
Present eliminates the large shoulder of Absent probe sets,
leaving a distribution that is more nearly normal (Fig. 1B).
It is important to note that the signals for all samples in a
particular probe set are treated as a group; all are retained
or all removed based on whether at least one experimental
group (interferon treated or control, in this example)
meets the filtering criterion. In Fig. 1, signal values for
probe sets for individual samples are shown, hence the
retention of some Absent samples after filtering. An alter-
native method of removing probe sets thought to repre-
sent genes with little or no expression is to set a minimum
average signal level for at least one of the two experimen-
tal groups. Fig. 1C shows the distribution of signal values
when a minimum average signal of 475 is required; 475
was chosen to retain a similar number of probe sets as the
50% Present filter shown in Fig. 1B. Filtering based on the
signal values more severely truncated the low expression
values (Fig. 1C).
The distribution of RMA values (Fig. 2A) has a greater
abundance of probe sets with low values than does the
MAS5 signal, and more of the probe sets called Present
have low values (compare Figs. 1A and 2A). Filtering by a
threshold of 50% Present leaves many of the low-level
Present probe sets (Fig. 2B). In contrast, filtering by the
average RMA value ≤5.03, which removes a comparable
number of probe sets, removes the low probe sets and
truncates the left-most portion of the graph (Fig. 2C).
Effects of different filtering thresholds
We explored the effect of setting different thresholds for
both types of filtering on the percentage of probe sets
retained that have each detection call (A, P, M). When
Percent of probe sets remaining after filtering Figure 3
Percent of probe sets remaining after filtering. Per-
cent of probe sets remaining after filtering using selected 
thresholds for A) Fraction Present. B) MAS5 Signal. C) RMA 
value.
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adjusted to remove comparable numbers of probe sets, fil-
tering by fraction Present does better at retaining probe
sets called Present. About 37% of the probe sets are Absent
on all 20 arrays, and are therefore removed by the fraction
Present filter set to any fraction greater than 0 (Fig. 3A).
No Present probe sets were removed until the threshold
was at least 20%, by which point 81% of the Absent probe
sets were removed. Setting the fraction Present to 50%
removes 4.2% of the Present probe sets along with 92% of
the Absent probe sets (Fig. 1B and 3A). Filtering by either
signal value (Fig. 3B) or RMA value (Fig. 3C), when
adjusted to remove a comparable number of probe sets,
leaves a less favorable balance between Absent and
Present probe sets. Unlike filtering by fraction Present, sig-
nal-based filtering removes Present probe sets even when
using a very low minimum MAS5 signal: a minimum
MAS5 signal of 254 leaves the same number of probe sets
as the Present filter set at >0%; at that signal threshold,
2.7% of the Present probe sets are removed along with
66% of the Absent probe sets. For RMA the balance
between removing Absent and Present probe sets is even
worse: the equivalent threshold of 4.25 removes 12.1% of
Present probe sets and 57% of Absent. As the signal value
is increased beyond that, a greater fraction of Present
probe sets is removed. Average Signal or RMA value
thresholds that leave a number of probe sets equal to the
results of using 50% Present remove 11.3% and 21.6% of
Present probe sets while only removing 86% and 77% of
the Absent probe sets (for MAS5 signal or RMA value,
respectively; Figs. 3B, 3C).
There was substantial agreement among the filtering
methods in which probe sets were retained when the
thresholds were chosen to retain comparable numbers of
probe sets (Table 1). Between 85 and 89% of the probe
sets retained with the fraction Present filter were also
retained when filtering by minimum MAS5 signal. The
agreement was less when filtering by RMA values, with
only 77% of the probe sets in common. Similar findings
are seen for the vitamin A data (Table 1). Very few probe
sets with p ≤ 0.001 are lost by filtering and the overlap
between signal and fraction Present filtering is better with
MAS5 data than RMA data (Table 2). [Note that the signal
and RMA values that remove similar numbers of probe
sets are quite different for the vitamin A data than for the
IFN data.] Increasing the stringency of filtering decreases
the number of probe sets with nominally significant p-val-
ues, as expected, but the more significant probe sets (p ≤
0.01 and p ≤ 0.001) are the least affected (Fig. 4, Table 2).
The FDR for any particular p-value is an estimate of the
percentage of probe sets expected to be false positives for
the group of probe sets that have a p-value less than or
equal to the selected p-value. FDR is based on the number
of probe sets used in the analysis (retained after the filter-
ing). Filtering by fraction Present or by signal or RMA
value have similar effects on the FDR calculated according
to Benjamini and Hochberg [1] (Fig. 5). The largest step-
wise improvement in FDR occurs with the initial filtering,
Present fraction > 0% or removal of an equivalent number
of probe sets by an average MAS5 signal ≥ 254 or RMA
Table 1: Probe sets remaining at different filtering thresholdsa.
Unfiltered 
(total)
FP>0
sig254
RMA4.25
FP25
sig375
RMA4.75
FP50
sig475
RMA5.03
FP75
sig593
 RMA5.30
FP100
sig795
RMA5.65
IFN Data
Fraction Present 22,283 14,035 11,906 10,678 9,545 8,050
Average Signal 22,283 14,030 11,888 10,657 9,546 8,057
Overlap (MAS5)b 89% 89% 88% 87% 85%
Average RMA value 22,283 14,118 11,909 10,687 9,526 8,076
Overlap (RMA)c 77% 77% 77% 77% 77%
Unfiltered 
(total)
FP>0
sig200
RMA5.05
FP25
sig265
RMA5.47
FP50
sig323
RMA5.70
FP75
sig400
 RMA5.95
FP100
sig475
RMA6.17
Vitamin A Data
Fraction Present 8799 4611 3981 3627 3237 2896
Average Signal 8799 4536 3988 3625 3231 2904
Overlap (MAS5)b 84% 84% 84% 83% 93%
Average RMA value 8799 4639 3984 3635 3229 2890
Overlap (RMA)c 73% 72% 72% 72% 71%
aFor comparison of different filters, thresholds were selected for each filter that removed similar number of probe sets. Types of filter: Fraction 
Present, 'FP' followed by threshold value; Average MAS5 signal, 'sig' followed by signal threshold; average RMA value, 'RMA' followed by threshold 
value. bThe percent of probe sets in common retained by both fraction Present and average MAS5 signal filter. cThe percent of probe sets in 
common retained by both fraction Present and average RMA value filter.BMC Bioinformatics 2006, 7:49 http://www.biomedcentral.com/1471-2105/7/49
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value ≥ 4.25. Increasing the stringency of the filter contin-
ues to improve the FDR. However, in the IFN experiment
(10 arrays in each group), increasing stringency beyond
25% Present, MAS5 signal ≥ 375, or RMA value ≥ 4.75
leads to little improvement in FDR for the more signifi-
cant probe sets (p ≤ 0.001), while increasing the number
of those very significant probe sets lost (Table 2). Results
for the smaller vitamin A data seta are similar (Table 2).
The smoking dataset (20 arrays per group) has higher var-
iability within each group. In those data, the fraction
Present filter shows a larger advantage over the average
signal filter, which increases with increasing stringency
(Fig. 5C).
The Benjamini and Hochberg [1] FDR is conservative. An
alternative FDR algorithm described by Storey and Tib-
shirani [2] produced FDR estimates that were about 50%
better (smaller) than those shown in Fig. 5A. Like the Ben-
jamini and Hochberg FDR, the Storey FDR was improved
by more than 50% when the data were filtered using a
threshold of 25% Present.
Permutation analyses
We used permutations of the IFN data in which 5 samples
from each treatment group were combined to produce
two new groups expected to show no difference. Welch's
t-tests on the MAS5 log transformed data produced fewer
nominally significant probe sets than expected by chance
(Table 3): 0.04 at a nominal p = 0.05 and 0.0005 at a
nominal p = 0.001. In these balanced permutations, 37%
of probe sets are Absent on all arrays but 43% of the probe
sets with p ≤ 0.05 are found in this "all-Absent" group,
demonstrating that the Absent probe sets make a dispro-
portionate contribution to false positives. Similar analyses
of the smoking data (Fig. 5C) also produced fewer nomi-
nally significant probe sets than expected by chance.
To determine if filtering would also improve other types
of analyses, we analyzed the IFN MAS5 data either unfil-
tered or after filtering by fraction Present with thresholds
of >0%, 25% and 50% using Significance Analysis of
Microarrays (SAM) [19]; SAM uses permutations to calcu-
late an FDR (q-value). Filtering by fraction Present
increased the number of probe sets deemed significant at
each FDR, demonstrating that filtering is beneficial for
this alternate method of determining significant changes.
Table 2: Highly significant (p ≤ 0.001) probe sets lost at different filtering thresholdsa.
Unfiltered 
(total)
FP>0
sig254
RMA4.25
FP25
sig375
RMA4.75
FP50
sig475
RMA5.03
FP75
sig593
 RMA5.30
FP100
sig795
RMA5.65
IFN Data
Fraction Present (MAS5) 1230 20 30 49 84 165
Average Signal (MAS5) 1230 8 26 43 57 112
Fraction Present (RMA) 1641 53 92 143 218 334
Average RMA (RMA) 1641 92 161 205 252 346
Unfiltered 
(total)
FP>0
sig200
RMA5.05
FP25
sig265
RMA5.47
FP50
sig323
RMA5.70
FP75
sig400
 RMA5.95
FP100
sig475
RMA6.17
Vitamin A Data
Fraction Present (MAS5) 168 8 10 10 14 17
Average Signal (MAS5) 168 5 9 13 19 24
Fraction Present (RMA) 177 5 7 10 14 18
Average Signal (RMA) 177 13 17 22 28 31
aFor comparison of different filters, thresholds were selected for each filter that removed similar number of probe sets. Types of filter: Fraction 
Present, 'FP' followed by threshold value; Average MAS5 signal, 'sig' followed by signal threshold; average RMA value, 'RMA' followed by threshold 
value. Total number of probe sets with p ≤ 0.001, followed by the number removed at each threshold (cumulative).
Table 3: Average fraction of false positives: permutation tests.
Nominal P-value
0.050 0.010 0.0010
Unfiltered 0.039 0.007 0.0005
All Absent 0.045 0.008 0.0007
Fraction Present >0 0.035 0.006 0.0005
Permutation of the MAS5 data such that no true positives would be 
expected were carried out 1000 times. Results shown are the average 
fraction called significant by the Welch's t-test for selected p-values 
(0.05, 0.01 and 0.001). Results are for unfiltered data, probe sets 
called Absent for all samples (37% of the probe sets), and data filtered 
using fraction Present >0.BMC Bioinformatics 2006, 7:49 http://www.biomedcentral.com/1471-2105/7/49
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Comparing fraction Present >0% to unfiltered data, there
was a 35% improvement in the number of probe sets sig-
nificant at 1% FDR. In this 10-sample experiment, more
restrictive filtering (25% and 50%) did not result in appre-
ciable improvement over >0% Present.
Effects on genes turned on or off
The most pronounced difference between filtering by frac-
tion Present and by average signal is the effect on probe
sets that are turned "on" or "off". Genes that are turned on
or off are of particular biological interest. In the IFN data
there are 108 probe sets that met our criteria for being
turned on or off (Table 4); there are 31 in the vitamin A
data. Filtering by fraction Present, none of these probe sets
were removed when the threshold was ≤ 50% for either
data set. Filtering by signal value, on the other hand,
removed "on/off" probe sets at each of the selected thresh-
olds (Table 4). Demanding that all probe sets be Present
in one of the two conditions leads to a 70% decrease in
the detection of probe sets turned on or off in IFN data
and an approximately 50% decrease for the vitamin A
data.
Effects of using fraction present in entire experiment 
rather than by treatment group
Our approach of requiring at least one group to meet the
threshold insures that the gene is expressed at a detectable
level in at least one biologically defined group; that seems
a priori preferable to requiring a (lower) fraction present
across the entire experiment, because the latter could
include genes that are not reliably detected in any biolog-
ical condition. To examine whether our choice led to a sig-
nificant bias, we compared these two approaches. Using a
fraction Present >0 (requiring just a single Present array)
is, of course, identical for both methods. Comparing
thresholds of 25% or 50% Present in at least one group
(our method) with thresholds across the entire experi-
ment that led to retention of similar numbers of probe
sets, the number significant at any particular p-value was
within 2%. filtering based on fraction Present in at least
Number of significant probe sets after filtering Figure 4
Number of significant probe sets after filtering. A) Filtering by fraction Present vs. by average MAS5 signal. The probe 
sets called significantly different (at the p-values shown) between the interferon treated and untreated samples in the 10 sample 
experiment are plotted against the threshold of Fraction Present (FP) or average signal (S), followed by threshold value. The 
horizontal line at 1230 indicates the number of probe sets at p ≤ 0.001 in the unfiltered data. Paired thresholds remove compa-
rable numbers of probe sets, e.g. FP>0 and S254. B) Filtering by fraction Present vs. by average RMA value. (FP) Fraction 
Present, (R) average RMA value, followed by threshold value. The line at 1641 indicates the number of probe sets at p ≤ 0.001 
in the unfiltered data.
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one group was much better at preserving probe sets turned
on or off than using a global threshold.
Effects of sample size on power
Most of the experiments completed by our core facility
have fewer than 10 samples per treatment group, typically
4–6, and some in the literature use fewer than 4. To under-
stand the effects of sample size on filtering we created
smaller virtual experiments (with 3, 4, 5, 6, 7, and 8 sam-
ples per treatment group) from the IFN data by using per-
mutations of the original data. We randomly selected
arrays without replacement within each treatment group;
this created virtual experiments in which a difference in
expression is expected. There is a large increase in power
as the sample size increases (Fig. 6) especially for the most
significant probe sets (p ≤ 0.001): a 15-fold increase from
3-sample experiments to 8-sample experiments. The
effects of filtering in the smaller experiments were similar
to the effects seen in the full experiment (Fig. 6). The more
significant probe sets (p ≤ 0.001) were mostly retained
when filtering was at ≤ 50% Present (Table 5). The FDR is
similarly improved by filtering (Fig. 7; note the differences
in scales in each panel for Figs. 6 and 7). Similar permuta-
tions were performed using the Smoking data for samples
sizes of 6, 10 and 14. The number of probe sets with p ≤
0.001 increased nearly 3-fold going from 6 to 10 samples;
increasing to 14 sample added another 70% and the full
20 samples had a further 60% improvement over 14.
We carried out a second set of permutations this time ran-
domly selecting equal numbers of samples from each
treatment group to create two new groups expected to pro-
duce no true positives. For these tests of 4, 6 and 8 samples
in each treatment group, a disproportionate number of
the false positives were found in the probe sets that are
Absent for all arrays (Table 6). the number found signifi-
cant was less than expected for a normal distribution,
results that are similar to the results of permutation tests
on the full data set.
Effect of sample size and filtering on consistently 
significant probe sets
While there is no gold standard for the IFN data, the full
10-sample dataset provides a reasonable standard to
which the smaller virtual experiments can be compared.
The Benjamini and Hochberg [1] FDR for the full experi-
ment (without filtering) at p = 0.05 is 25%, the Storey [2]
FDR is 17%, and the estimate by permutation is 20%.
Therefore, a crude estimate of false discovery can be made
by comparing the results from the small experiments to
the results using all samples, assuming that any probe set
that was called significant in the smaller experiments but
had a p-value > 0.05 in the full experiment (without filter-
ing) was a false positive. The number of false positives
identified in this manner is slightly smaller than was
Effect of Filtering on false discovery rate (FDR) Figure 5
Effect of Filtering on false discovery rate (FDR). Filter 
method and values (x-axis): Fraction Present (FP), signal (S) 
or RMA value (R) followed by threshold value; separate lines 
are shown for each. Closed circles represent values from 
fraction Present filtering, open diamonds from average signal 
or average RMA. P-values: 0.05 (blue), 0.01 (pink), and 0.001 
(green). A) IFN data, MAS5, B) IFN data, RMA, C) Smoking 
data, MAS5. Note that the smoking data was scaled to 100 
instead of 1000 used for the other data sets.
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found by permutations, and remains about constant for
experiments of size 3 to 8 samples per treatment group
(Fig. 8). The number identified as "true positives" (i.e.
matching the full 10 sample experiment) at p ≤ 0.05
increases with the size of the experiment. Filtering at 50%
Present removes about 50% of the false positive probe sets
across the full range of sizes, and removes from 11.6% (3
samples) to 18.4% (8 samples) of the true positive probe
sets (primarily those with p > 0.01). This suggests that
larger experiments do not need as stringent a fraction
Present filter.
Another way of analyzing the likely true positives in
smaller experiments is by examining the reproducibility
of results. We assumed that probe sets deemed significant
at least 50% of the time (i.e. in ≥ 500/1000 permutations)
represents consistent, reproducible data. The number of
consistently significant probe sets increases as the experi-
ment size increases and approaches the number identified
as true positive probe sets (Fig. 8). In the smaller virtual
experiments (3 or 4 samples per treatment group) only 2–
4% of the probe sets consistently significant at p ≤ 0.05 are
lost when filtering by 50% Present. In larger experiments
(5 or 6 samples per group) 6–9% of these consistently sig-
nificant probe sets were lost when filtering by 25%
Present (Fig. 8). For those probe sets consistent at p ≤
0.01, the number lost by filtering is even smaller, almost
none for 3–4 samples at 50% Present and 1–2% for 5–6
samples per group at 25% Present. Only 2 probe sets in
the 3-sample permutations were found to be significant at
p ≤ 0.001 at least 50% of time, whereas 65 such probe sets
were found in the 4-sample permutations. All of these
were retained by fraction Present filtering at all thresholds.
In contrast to removing probe sets that represent genes
not expressed, setting a fold change limit by itself does not
appear to increase the likelihood that a change is in fact
real. Absent probe sets with low signals have an increased
probability of generating spurious large fold changes,
especially in smaller experiments (3–5 samples). For these
small experiments, the probe sets remaining after 50%
Present filter generate a modest number of fold changes
≥2 of which 71–84% are called significant in the full 10-
sample experiment at p ≤ 0.01. On the other hand those
probe sets removed by the 50% filter generate about 4
times as many fold changes ≥2, of which only 6 to 10%
are called significant in the 10-sample experiment at p ≤
0.01.
Discussion
Microarray experiments allow one to examine global pat-
terns of gene expression, but by their nature involve mul-
tiple comparisons that can generate false positives. While
the idea of removing probe sets that are unlikely to pro-
duce positive results is not new, we present a systematic
Effect of filtering on average number of significant probe sets  in smaller experiments Figure 6
Effect of filtering on average number of significant 
probe sets in smaller experiments. Smaller virtual 
experiments (4, 6 and 8 samples per treatment group) were 
created by random selection of arrays within each of the two 
treatment groups (based on 1000 permutations). The probe 
sets called significantly different (at the p-values shown) are 
shown for different values of fraction Present (x-axis). Note 
differences in scale for y-axes of the 3 graphs. P-values: ≤ 
0.05 diamond, ≤0.01 square, ≤0.001 triangle.
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analysis of the effects of several strategies. Not all genes are
expressed in any one tissue [3]. Probe sets that have very
low signals or are called Absent primarily reflect noise in
the data, and give a large number of false positives with-
out adding many true positives. Permutations expected to
produce no significant changes confirmed that Absent
probe sets have an increased risk of producing false posi-
tives (Tables 3 and 6). Requiring that only one treatment
group meet the threshold, particularly with our recom-
mended filtering by Fraction Present, preserves data for
genes that are turned on or off, genes that may be of great
interest to biologists.
Filtering by fraction Present does a better job of removing
most of the Absent probe sets while retaining most of the
Present probe sets than filtering by either average MAS5
signal or RMA value (Figs. 1, 2 and 3), and results in much
better FDR (Fig. 5, 7). Our main evaluation criteria,
improvement of FDR, was chosen because this experi-
ment-wide measure of confidence is widely applied.
Because there is no "gold standard" for real experiments,
we used measures that increased the likelihood of a result
being a true positive, such as p-value < 0.001 for a Welch's
t-test and consistency of detecting the difference in multi-
ple permutations. Fraction Present filtering removes very
few probe sets with p ≤ 0.001 (Fig. 4 and 6, Tables 2 and
5); it does not remove probe sets that are turned on or off
unless the threshold is set above 50% Present (Table 4).
Unlike using signal or RMA values, thresholds chosen for
fraction Present are not affected by chip type, percent
called present, method of scaling or normalization, nor by
the method used to produce the expression value (e.g.
MAS5, RMA).
Permutation of the IFN data to simulate smaller experi-
ments also showed that the Absent probe sets generated a
disproportionate number of false positives (Fig. 8, Table
6) many of which had fold changes larger than 2, showing
that fold-change alone as a filter cannot fix this problem.
Filtering increased the average number of probe sets that
met an FDR of 0.1 in the IFN data for experiments of all
sizes (Fig. 9), and was particularly helpful for the smaller
experiments: over 3-fold improvement for the 3 sample
experiments (38 to 122) and nearly double for the 4 sam-
ple experiments (378 to 672). Small experiments (3–4
samples) have limited power to detect changes, and very
few probe sets can be consistently identified (Fig. 8). Fil-
tering by fraction Present greatly improves FDR even for
small experiments, and retains nearly all of these repro-
Table 4: Number of on/off probe sets retained after filtering at selected thresholds.
IFN data Unfiltered FP>0
sig 254
FP25
sig375
FP50
sig475
FP75
 sig593
FP100
sig795
Fraction Present 108 108 108 108 90 34
Average Signal 108 104 100 89 81 64
Vitamin A data FP>0
sig 200
FP25
sig265
FP50
sig323
FP75
sig400
FP100
sig475
Fraction Present 31 31 31 31 27 16
Average Signal 31 26 22 17 16 13
Filtering by Fraction Present (FP) and average MAS5 signal (sig) followed by threshold. On/off: probe sets with p < 0.05 for t-test and in which the 
sum of Present calls differed by more than 6 for IFN data and more than 4 for vitamin A data between the two treatment groups were called turned 
"on" or "off".
Table 5: Number of very significant probe sets lost after filtering in smaller experiments.
Probe sets at p 
≤ 0.001
Probe sets at p ≤ 0.001 lost by filtering at selected thresholds
# samples Unfiltered > 0% ≥ 25% ≥ 50% ≥ 75% 100%
3 59 10 10 11 12 13
4 165 12 12 14 16 20
5 333 12 14 16 21 28
6 528 12 14 18 27 43
7 718 14 17 25 40 68
8 897 16 21 32 50 99
Number of probe sets at p ≤ 0.001 found in the unfiltered IFN data, and the number of those lost by filtering at each of several fraction Present 
thresholds, for experiments with 3 to 8 samples per treatment group.BMC Bioinformatics 2006, 7:49 http://www.biomedcentral.com/1471-2105/7/49
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ducible probe sets (Figs. 7, 8). While we think that exper-
iments should use more than 3 or 4 samples, this filtering
method should improve results from small experiments
such as pilot projects.
Pavlidis, et al. [20] demonstrated that 10 to 15 samples
(or fewer in some cases) produced reproducible results, as
determined by their stability measures of order and recov-
ery. Our study demonstrates that even large experiments
benefited from filtering by fraction Present; The IFN data
with 10 samples and the smoking data with 20, both had
improvements in FDR after filtering (Fig. 5), with approx-
imately a 50% improvement in FDR when using a fraction
Present of 0.25 for filtering.
Removing only those probe sets called Absent in all sam-
ples provides the single largest improvement in FDR and
appears to be sufficient for large experiments. Although
the FDR is somewhat better with more stringent filtering
(Fig. 7), the loss of probe sets at p ≤ 0.001 indicates there
may be an accelerated loss of true positives in the larger
data sets (Table 5). as the experiment size decreases, the
criterion for filtering should be increased (Fig. 6, 7; Table
5). For data sets with 3–4 samples 50% Present spares
most of the probe sets significant at p ≤ 0.001 and those
probes sets found most consistently (Fig. 6, 8). For more
samples, relaxing the threshold to 25% fraction Present is
reasonable (Fig. 6, 7, and 8). Requiring 100% Present in
one of the two treatment groups is not recommended,
because it removes too many highly significant probe sets
(Tables 2 and 5) and removes a large portion of the probe
sets turned on or off (Table 4) in experiments of any size.
The results are similar for datasets that differ greatly. The
IFN data, presented in the most detail, was from an exper-
iment that examined the effects of interferon treatment on
human PBMC in vitro [16], and used the HGU133A Gene-
Chip®. The vitamin A data compared RNA extracted from
liver tissue from Sprague-Dawley rats fed vitamin A defi-
cient or sufficient diets [15,21], and used the relatively old
RGU34A GeneChip®, designed with much less sequence
data and informatics. The smoking data are from a large
study examining differences in bronchial epithelia
extracted from human subjects [22], and also used
HGU133A GeneChip®; the variability within each group
in the smoking dataset is much greater than in the others.
The Pearson correlation between samples from subjects
within each of the two groups in the smoking data were
0.87 and 0.89, compared to an average Pearson correla-
tion >0.97 for samples within each group for the IFN data.
In all three cases, representing different generations of
GeneChip®, different species, different laboratories and
different amounts of intra-group variability, our approach
achieved the primary goal of improving FDR while mini-
Effects of filtering on FDR in smaller experiments Figure 7
Effects of filtering on FDR in smaller experiments. 
FDR for the smaller virtual experiments shown in Fig. 6. 
Note differences in scale for y-axes of the 3 graphs. P-values: 
≤ 0.05 diamond, ≤0.01 square, ≤0.001 triangle.
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mizing the removal of very significant probe sets (p ≤
0.001) and retaining those probe sets turned on or off.
Filtering based on the fraction of Present calls is superior
to methods based on signal or RMA value because it is
more likely to preserve probe sets turned on or off and it
removes probe sets that show cross-hybridization. Filter-
ing by fraction Present is also much easier to implement,
because general guidelines can be set based upon the
experiment size instead of having to examine the distribu-
tion of signal values; the variability of the signal distribu-
tions for different datasets is such that no average signal
value gives comparable results across all datasets (Table
1). Although the detection call is generated by MAS5, this
method can be used as a pre-filter to improve results using
non-MAS5 generated data, such as RMA.
Table 6: Fraction of false positives in smaller experiments.
Unfiltered All Absent Fraction Present >0
# samples 0.050 0.010 0.0010 0.050 0.010 0.0010 0.050 0.010 0.0010
4 0.029 0.005 0.0005 0.035 0.007 0.0009 0.030 0.005 0.0004
6 0.036 0.006 0.0005 0.041 0.007 0.0007 0.033 0.005 0.0004
8 0.039 0.006 0.0050 0.044 0.008 0.0007 0.035 0.006 0.0004
Permutations generating smaller experiments with 4, 6, or 8 samples per treatment group of the IFN MAS5 data such that no true positives would 
be expected were carried out 1000 times. Results shown are the average fraction called significant by the Welch's t-test for selected p-values (0.05, 
0.01 and 0.001). Results are given for unfiltered data, probe sets called Absent for all samples, and data filtered using fraction Present >0.
Effect of experiment size on true positives, false positives and consistent positives Figure 8
Effect of experiment size on true positives, false positives and consistent positives. TP: true positive, p-value ≤ 0.05 
in smaller simulated experiment and p ≤ 0.05 in full 10-sample analysis. FP: false positive, p-value ≤ 0.05 in smaller simulated 
experiment but p > 0.05 in full 10-sample analysis. 500/1000: consistent positives, found significant at p < -0.05 in at least 50% 
of the 1000 permutations. Data are shown both unfiltered and after filtering by 50% Present.
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Conclusion
Filtering out data that are not reliably detected by setting
a threshold for fraction of arrays (in at least one treatment
group) in which the probe set is called Present by the
MAS5 algorithm is a simple, easy to implement approach
that works well to reduce false positives with little cost in
loss of true positives. It is superior to using the average sig-
nal or RMA value because it is more likely to preserve
probe sets turned on or off and it removes probe sets that
show cross-hybridization. Another advantage is that filter-
ing by fraction Present is much easier to implement,
because general guidelines can be set based upon the
experiment size instead of having to examine the distribu-
tion of expression values.
Filtering by fraction Present improves both parametric
(Welch's t-test) and non-parametric analyses (e.g. SAM).
For t-tests, this type of filtering rarely removes very signif-
icant probe sets (p ≤ 0.001). Although similar results in
FDR improvement can be achieved filtering by average
signal or RMA value, approaches based on expression
level are more likely to remove genes that are being turned
on or off. Permutations of data expected to produce no
true positives resulted in fewer false positives than pre-
dicted by the Benjamini and Hochberg method [1], and
demonstrated that probe sets called Absent produce a dis-
proportionate fraction of false positives.
Using fold change by itself for filtering is problematic.
Probe sets that are all or mostly Absent (with low signals)
can generate large fold changes (due to dividing by values
near zero) that are not reproducible, and represent false
positives.
Smaller experiments benefit from filtering with a thresh-
old of 0.5 or higher (a higher threshold of fraction
Present); criteria can be relaxed for larger experiments
although filtering is still of substantial value. Setting the
threshold to 100% Present (all probe sets Present in at
least one treatment group) is too stringent for experiments
Effect of experimental size on number of probe sets meeting a fixed value of FDR before and after filtering Figure 9
Effect of experimental size on number of probe sets meeting a fixed value of FDR before and after filtering. The 
number of probe sets meeting various Benjamini and Hochberg FDR thresholds, 0.2 (blue), 0.1 (red), and 0.05 (green) before 
(open symbols) and after filtering (filled symbols) by 50% Present. Number selected is average over 1000 permutations.
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of any size, because it removes many of the genes being
turned on or off and removes a large proportion of very
significant genes with little improvement in FDR.
Methods
Experimental data
Three datasets were used for this analysis. The primary
data set was taken from a previously reported experiment
on the effects of 500 U/ml pegylated interferon alpha and
10  µg/ml ribavirin on peripheral blood monocytes
(PBMC) in culture [16]("IFN data"). PBMC were isolated
from different individuals and aliquots exposed to inter-
feron, ribavirin, both or neither for 24 hours in culture.
The individual samples were processed and each hybrid-
ized to a HGU133A GeneChip®  following standard
Affymetrix protocols. The previous analysis of the IFN
data determined that the ribavirin had no detectable effect
on gene expression [16]; therefore, to increase the power
to detect changes the arrays from the no treatment group
and the ribavirin only group were combined to create a
control group of 10 samples, and the interferon and inter-
feron + ribavirin groups were combined to create an inter-
feron-treated group of 10 samples [16].
The second dataset is from a study that compared gene
expression in liver from male rats fed a diet deficient in
vitamin A to a control group fed the same diet plus vita-
min A ("vitamin A data") [15,21]. That study used
Affymetrix RGU34A GeneChips. Data for all 14 arrays are
available from Gene Expression Omnibus at NCBI, acces-
sion numbers GSM27430 through GSM27443 and
GSE1600.
GeneChips® for both of these experiments were processed
in The Center for Medical Genomics at Indiana University
School of Medicine. Affymetrix Microarray Suite 5.0 was
used to generate signal values and detection calls and the
data were exported for further analysis. Both of these data
sets were globally scaled to a target of 1000; default
parameters were used for the detection call algorithm. We
also used the R package "Affy", which is part of the Bio-
conductor Project [23], to calculate an alternate measure
of expression level using the default parameters for the
robust multichip average (RMA) algorithm [17,18].
The third dataset was taken from the GEO database, GDS
accession number GDS534 and reported by Spira, et al.
[22]. This study compared bronchial epithelia from
humans who were current smokers, never smoked or were
former smokers. From this data we selected 20 samples
from the current smokers and never smoked groups
("smoking data"). Three samples were omitted because
their correlation coefficients with samples in the same
group were particularly low, GSM15689 and GSM15692
(current smokers) and GSM15728 (never smoked). The
current smoker samples used were GSM15684-
GSM15688, GSM15690, GSM15691, GSM15693,
GSM15695-GSM15702, and GSM15704-GSM15707;
never smoked samples were GSM15718-GSM15727 and
GSM15729-GSM15738. These samples were analyzed
using MAS5 and were scaled to target intensity of 100. The
GEO contained signal and detection p-value. We gener-
ated detection calls from the detection p-value using the
MAS5 defaults (Present: p < 0.04, Marginal: 0.04 ≤ p <
0.06, Absent: p ≥ 0.06).
Filtering methods
Two classes of filtering methods were evaluated. Both
made decisions about retaining a probe set in the analysis
based on the behavior of the probe set on the arrays in at
least one treatment group. If the probe set passes the filter
criteria in either group, all signal values for that probe set
are retained for both groups regardless of the signal value
or detection call for any individual array. Note that this
retains probe sets Present in one treatment group and
Absent in the other; these can be very interesting biologi-
cally. When a probe set does not meet the threshold for
either group it is rejected, and signal values for all samples
are removed for this probe set. The two methods were
applied to data generated by MAS5 and RMA separately.
For comparison, filtering was also done using the fraction
called present for all arrays.
Filtering by fraction Present
The first method used the fraction called Present in at least
one treatment group to filter. For each probe set on each
array, MAS5 provides a detection call, Absent (A), Present
(P) or Marginal (M), which indicates whether the specific
mRNA is detectable. The detection call in MAS5 is based
on a non-parametric statistical test (Wilcoxon signed rank
test) [5] of whether significantly more perfect matches
show more hybridization signal than their corresponding
mismatches. For each probe set, the number of Present
and Marginal calls in each treatment group were summed
using a value of 1 for Present and 0.51 for Marginal. Probe
sets that met or exceeded a particular threshold of fraction
Present in at least one treatment group were retained. For
example using the IFN data, for a 50% fraction Present fil-
ter, probe sets were retained if the "number Present" was
at least 5 in either treatment group for the 10 × 10 experi-
ment; for 25% the number Present must be at least 2.5 in
either treatment group. RMA does not provide a measure
comparable to the MAS5 detection call, therefore we used
the MAS5 detection call to filter the RMA data sets as well.
Filtering by average signal
The second method used the average expression level for
each treatment group for filtering and was applied to both
the MAS5 and RMA datasets For each probe set, MAS5 sig-
nals and RMA values were averaged for each treatmentBMC Bioinformatics 2006, 7:49 http://www.biomedcentral.com/1471-2105/7/49
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group separately. A probe set was retained if the average
expression level (MAS5 signal or RMA value) met or
exceeded the selected threshold value in at least one treat-
ment group. For example, using a filter of 100 for the
MAS5 signal, probe sets are retained if the average signal
for either treatment group met or exceeded 100.
Comparison of methods
We compared the two methods when comparable num-
bers of probe sets were retained for analysis. To do this, for
each of the selected fraction Present thresholds, we calcu-
lated the number of probe sets retained and set an average
threshold for either MAS5 signal or RMA value that
retained a comparable number of probe sets. For example,
using the IFN data, 10,678 probe sets were retained after
filtering by a fraction Present threshold of 50%; therefore
we selected an average signal of 475 to retain 10,675
probe sets and an average RMA value of 5.03 to retain
10,687 probe sets for comparison.
To compare fraction Present thresholds by treatment
group to fraction Present for all arrays, a threshold for the
"all arrays" method was selected such that a similar
number was retained by both methods.
Differences in gene expression
To provide the baseline for comparisons in this analysis,
we performed a Welch's unpaired t-test [24] on both the
RMA values and the log base 2 of the MAS5 signal values
to determine if there were differences in expression level
between the treated and untreated groups. Since the MAS5
signal is bounded by 0 on the left and has a long heavy tail
to the right, the MAS5 data were log-transformed for the
analysis to produce a more nearly normal distribution
(Fig. 1). RMA is already a log-based measurement. Signif-
icant differences were also identified using the Signifi-
cance Analysis of Microarrays (SAM) algorithm [19]. SAM
was performed using MAS5 data both unfiltered and fil-
tered by fraction Present at selected thresholds. All SAM
analyses were done using unpaired data, 500 permuta-
tions and the 10-Nearest Neighbor Imputer. The "delta
table" from each SAM analysis was used for comparisons
between these data sets.
Genes which had a p-value ≤ 0.05 for the difference
between groups (t-test) were evaluated for whether they
were turned on or off. If the sum of Present calls differed
by more than 6 in the IFN data (6 of 10) and more than 4
in the vitamin A data (4 of 7) genes were called turned
"on" or "off" depending on the direction of change.
Point estimates for the false discovery rate (FDR) at partic-
ular p-values were calculated by determining how many
probe sets would be expected to be significant by chance
(assuming a normal distribution) and dividing that by the
number of probe sets that met that p-value threshold. The
FDR was calculated using the number of probe sets
retained after filtering. This is similar to FDR estimates
from Benjamini and Hochberg [1].
(p-value) * (number of probe sets remaining after filter-
ing)/(number significant at that p-value)
FDR values were also calculated using the q-value pro-
gram [2]. P-values generated by the Welch's t-test from
unfiltered and filtered MAS5 datasets were used as input
to calculate FDR values.
As another estimate of the number of false positives, we
carried out balanced permutations designed such that
there should be no true positives. For the IFN data, arrays
were randomly selected such that 5 from each actual treat-
ment group of 10 samples were selected for one group and
the remaining 10 samples (5 from each group) were used
as the second treatment group. For the smoking data, 10
arrays each were randomly selected from the non-smokers
and smokers groups for the first treatment group and the
remainder used for the second treatment group. Thus each
permuted group had equal numbers of arrays from both
groups, and the comparison is expected to show no differ-
ence. Permutation were carried out 1000 times. For each
probe set, totals were kept for the number of times that a
probe set met a selected combination of p-value and frac-
tion Present threshold (p-values: 0.05, 0.02, 0.01 and
0.001; fraction Present: no filter, >0%, 25% 50%, 75%
and 100%). Experiment-wide totals (total number of
probe sets meeting the criteria) are an average of the 1000
permutations.
Testing effects of sample size by permutation
In addition to the analyses performed using all of the
arrays, we tested the effects of number of arrays on both
true and false positives. To mimic smaller experiments
testing the effects of interferon, we generated smaller vir-
tual experiments from the MAS5 data by randomly select-
ing samples without replacement from within each
treatment group to generate sample sizes of 3, 4, 5, 6, 7,
and 8 arrays per group. 1000 permutations were com-
pleted for each sample size, and the results were tallied
and averaged as described above.
To examine the false positives in smaller experiments, we
generated balanced permutations from the IFN data in
which equal numbers of arrays were randomly selected
without replacement such that equal numbers were taken
from each treatment group. 1000 permutations were com-
pleted for sample sizes 4, 6 and 8 to give an estimate of
how many probe sets may be called significant by chance
for each sample size.BMC Bioinformatics 2006, 7:49 http://www.biomedcentral.com/1471-2105/7/49
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